Danaher announces leadership appointment

Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2021 its Board of Directors has appointed Jennifer L. Honeycutt to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company's Beckman Coulter Life Sciences, Integrated DNA Technologies (IDT), Leica Microsystems, Molecular Devices, Pall, Phenomenex, and SCIEX businesses. With this appointment, Ms. Honeycutt will become an executive officer of the Company.

Prior to this appointment, Ms. Honeycutt, 51 years old, was a Vice President and Group Executive overseeing Pall, IDT, and the Danaher Life Sciences platform in China , and served as President of Pall. She previously served as President of Beckman Coulter Life Sciences from 2013 to 2016 and is also a longstanding member of Danaher's Diversity + Inclusion Council.

In her new role, Ms. Honeycutt will continue to report directly to Rainer M. Blair , President and Chief Executive Officer.

Mr. Blair stated, "Jennifer's leadership has been an integral driver of the growth and success of Pall and our Life Sciences platform over the past several years. The combination of Jennifer's strong operational track record, innovative mindset and commitment to the Danaher Business System has enabled her to make a tremendous impact. Jennifer's twenty-year Danaher career exemplifies our Shared Purpose – Helping Realize Life's Potential – and we look forward to her continued successes and contributions in the years to come."

Ms. Honeycutt joined Danaher in 1999 via the acquisition of Hach and subsequently served in a series of progressively more responsible general management roles within Hach Ultra Analytics, Anderson Instrument Company and Linx Printing Technologies. Ms. Honeycutt started her career at Hach in 1991 as a research chemist. She earned B.A. degrees in Chemistry and French from Grinnell College and an MBA in Technology Management from the University of Denver .

ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of more than 67,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential . For more information, please visit www.danaher.com .

Cision View original content: https://www.prnewswire.com/news-releases/danaher-announces-leadership-appointment-301191639.html

SOURCE Danaher Corporation

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at... Keep Reading...
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the... Keep Reading...
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries CommenceDownload the PDF here. Keep Reading...

Latest Press Releases

Related News